Publication Precigen ActoBio’s Phase 1b/2a clinical trial results in Diabetologia journal

Publication Precigen ActoBio’s Phase 1b/2a clinical trial results in Diabetologia journal

Congratulations to Precigen Actobio for the publication of their Phase 1b/2a clinical trial results with AG019 in recent onset Type 1 diabetes in the Diabetologia journal

 

Curious about the article? Check here

 

Emtex’ contribution to this publication included:

 

– drafting of the manuscript based on source documents and implementing review comments of the authors,

– formatting figures and tables according to the journal’s guidelines,

– aligning the manuscript with the CONSORT checklist, and

– final editing and preparing for submission.

 

Are you also looking for medical writing support to successfully publish your scientific article? Do not hesitate to contact us!

Customer testimonial:

 

“My team has worked with Emtex Life Science for more than 15 years to our entire satisfaction. They are a highly competent and effective group of medical writers. A top team!”

Global Head Regulatory Medical Writing